News and Press Releases 2010

September 02, 2010
Orexigen® Therapeutics and Takeda Enter into Partnership to Commercialize Contrave® in North America
July 14, 2010
Takeda Responds to FDA Advisory Committee Recommendation
June 21, 2010
ACTOplus met® XR (pioglitazone HCl and metformin HCl extended-release) Now Available in Pharmacies Nationwide
June 21, 2010
New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan
June 21, 2010
AFFYMAX AND TAKEDA ANNOUNCE PHASE 3 TRIALS MEET PRIMARY ENDPOINTS FOR INVESTIGATIONAL DRUG, HEMATIDE™/PEGINESATIDE, TO TREAT ANEMIA IN CHRONIC RENAL FAILURE WITH SOME DIFFERENCES NOTED IN SECONDARY ANALYSES
May 3, 2010
Pivotal Phase 3 Data Demonstrated Investigational Compound Azilsartan Medoxomil Lowered Blood Pressure in Head-to-Head Comparator Trials
April 28, 2010
Takeda Provides Update on Patent Litigation for ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl) in the U.S.
April 27, 2010
Takeda Submits New Drug Application for Azilsartan Medoxomil in the U.S., an Investigational Compound for the Treatment of Hypertension
April 26, 2010
Proton Pump Inhibitor DEXILANT™ (dexlansoprazole) Now Available in U.S. Pharmacies
March 4, 2010
KAPIDEX™ (dexlansoprazole) Renamed DEXILANT™ in U.S. to Avoid Name Confusion
February 9, 2010
Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix^® (clopidogrel bisulfate)

Page Top